In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Reckitt Benckiser buys SSL International for £2.54bn in cash

Executive Summary

In an effort to expand its medicines and personal care offerings, Reckitt Benckiser PLC (household and health products) has agreed to acquire consumer health care company SSL International PLC for £2.54bn ($3.9bn) in cash. Shareholders will receive 1,163p per share (a 32% premium), plus an 8p dividend, for an aggregate of 1,171p.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies